...
首页> 外文期刊>Brain & Development >Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine.
【24h】

Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine.

机译:家族性偏瘫偏头痛的遗传诊断和乙酰唑胺治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

A female patient presented with horizontal gaze nystagmus, mild cerebellar ataxia, recurrent headache and hemiplegia since childhood with cerebellar atrophy on magnetic resonance imaging. Genetic analysis revealed a CACNA1A gene mutation, leading to a diagnosis of familial hemiplegic migraine (FHM1). FHM is very rare, but should be considered as a differential diagnosis for childhood cerebellar symptoms and/or cerebellar atrophy. To avoid missing FHM1, a detailed clinical history including headache or hemiplegia is essential. Oral acetazolamide during the aura phase, comprising mild headache and abnormal leg sensation, relieved these symptoms in this patient, suggesting that acetazolamide could represent a first line of treatment.
机译:一名女性患者自小就表现出水平凝视眼球震颤,轻度小脑共济失调,反复发作的头痛和偏瘫,并在磁共振成像中发现了小脑萎缩。遗传分析显示CACNA1A基因突变,导致诊断为家族性偏瘫偏头痛(FHM1)。 FHM非常罕见,但应被视为儿童小脑症状和/或小脑萎缩的鉴别诊断。为了避免丢失FHM1,包括头痛或偏瘫在内的详细临床病史至关重要。在先兆期口服口服乙酰唑胺,可缓解该患者的这些症状,包括轻度头痛和异常的腿部不适,这表明乙酰唑胺可以代表一线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号